184 related articles for article (PubMed ID: 15679766)
1. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
Graham DY; Opekun AR; Belson G; El-Zimaity HM; Carlson MR
Aliment Pharmacol Ther; 2005 Jan; 21(2):165-8. PubMed ID: 15679766
[TBL] [Abstract][Full Text] [Related]
2. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
4. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
de Boer WA; van Etten RJ; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 2000 Mar; 95(3):641-5. PubMed ID: 10710051
[TBL] [Abstract][Full Text] [Related]
5. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Graham DY; Belson G; Abudayyeh S; Osato MS; Dore MP; El-Zimaity HM
Dig Liver Dis; 2004 Jun; 36(6):384-7. PubMed ID: 15248377
[TBL] [Abstract][Full Text] [Related]
6. Pylera for the eradication of Helicobacter pylori infection.
Saleem A; Qasim A; O'Connor HJ; O'Morain CA
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
8. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Malfertheiner P; Bazzoli F; Delchier JC; Celiñski K; Giguère M; Rivière M; Mégraud F;
Lancet; 2011 Mar; 377(9769):905-13. PubMed ID: 21345487
[TBL] [Abstract][Full Text] [Related]
12. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
13. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
[TBL] [Abstract][Full Text] [Related]
14. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin for the cure of Helicobacter pylori infection.
Di Mario F; Dal Bó N; Grassi SA; Rugge M; Cassaro M; Donisi PM; Vianello F; Kusstatscher S; Salandin S; Grasso GA; Ferrana M; Battaglia G
Am J Gastroenterol; 1996 Feb; 91(2):264-7. PubMed ID: 8607490
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
[TBL] [Abstract][Full Text] [Related]
17. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G
Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419
[TBL] [Abstract][Full Text] [Related]
18. Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication.
Magalhaes AF; Macedo C; Hauck JR; Carvalhaes A; De Nucci G; Magna LA; Pedrazzoli J
Hepatogastroenterology; 1998; 45(24):2161-4. PubMed ID: 9951885
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Marko D; Calvet X; Ducons J; Guardiola J; Tito L; Bory F;
Helicobacter; 2005 Feb; 10(1):22-32. PubMed ID: 15691312
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]